News tagged with gefitinib

Need for national Canadian strategy for EGFR testing

Significant advances have taken place in the management of patients with advanced and metastatic non–small-cell lung cancer (NSCLC) over the last 5 years. Traditionally, all advanced NSCLC patients were treated in a similar ...

Jul 25, 2013
popularity0 comments 0


Gefitinib INN ( /ɡɛˈfɪtɨnɪb/), trade name Iressa, is a drug used in the treatment of certain types of cancer, particularly those with mutated and overactive EGFR. Gefitinib is an EGFR inhibitor, like erlotinib, which interrupts signaling through the epidermal growth factor receptor (EGFR) in target cells. It is marketed by AstraZeneca and Teva.

This text uses material from Wikipedia, licensed under CC BY-SA

Subscribe to rss feed